160 related articles for article (PubMed ID: 19567036)
1. [Current advances in molecular targeted therapy of primary hepatocellular carcinoma].
Yu L; Dai Z; Zhou J; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):475-7. PubMed ID: 19567036
[No Abstract] [Full Text] [Related]
2. Current problems with systemic treatment of advanced hepatocellular cancer.
He AR; Soe K; El Zouhairi M
Curr Probl Cancer; 2010; 34(2):131-49. PubMed ID: 20417353
[No Abstract] [Full Text] [Related]
3. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Yau T; Pang R; Chan P; Poon RT
Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of multiple targeted agents as potential therapies for hepatocellular carcinoma (HCC). Foreword.
Kummar S
Curr Probl Cancer; 2010; 34(2):130. PubMed ID: 20417352
[No Abstract] [Full Text] [Related]
5. [Hepatocellular carcinoma management in the era of sorafenib].
Rosmorduc O
Gastroenterol Clin Biol; 2009 Apr; 33(4):327-33. PubMed ID: 19321281
[No Abstract] [Full Text] [Related]
6. Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.
Kuzuya T; Tsuchiya K; Izumi N
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1883-86. PubMed ID: 21069944
[No Abstract] [Full Text] [Related]
7. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
Kelley RK; Venook AP
J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
[No Abstract] [Full Text] [Related]
8. Closing remarks.
Kudo M
Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
[No Abstract] [Full Text] [Related]
9. FDA approves sorafenib for patients with inoperable liver cancer.
Lang L
Gastroenterology; 2008 Feb; 134(2):379. PubMed ID: 18242200
[No Abstract] [Full Text] [Related]
10. Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma.
Lapecorella M; Napolitano M; Tudini M; Bruera G; Lucchesi A; Giordano AV; Mariani G; Ricevuto E
Haemophilia; 2010 Jan; 16(1):185-7. PubMed ID: 19804385
[No Abstract] [Full Text] [Related]
11. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.
Spira D; Fenchel M; Lauer UM; Claussen CD; Gregor M; Bitzer M; Horger M
Acad Radiol; 2011 Jan; 18(1):89-96. PubMed ID: 20926315
[TBL] [Abstract][Full Text] [Related]
12. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].
Boige V; Barbare JC; Rosmorduc O;
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):3-7. PubMed ID: 18341970
[No Abstract] [Full Text] [Related]
13. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Zhu AX
Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitors in development for hepatocellular carcinoma.
Wörns MA; Galle PR
Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
[TBL] [Abstract][Full Text] [Related]
15. From a cancer drug fund to value based pricing of drugs.
Duerden M
BMJ; 2010 Aug; 341():c4388. PubMed ID: 20705656
[No Abstract] [Full Text] [Related]
16. Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.
Lo CH; Chang CM; Tang SW; Pan WY; Fang CC; Chen Y; Wu PY; Chen KY; Ma HI; Xiao X; Tao MH
J Gene Med; 2010 May; 12(5):423-34. PubMed ID: 20440753
[TBL] [Abstract][Full Text] [Related]
17. Oesophageal variceal bleeding in hepatocellular carcinoma with portal vein thrombosis: improved outcome in response to molecular target therapy.
Wu SS; Yen HH; Chung CY
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):566-7. PubMed ID: 18555670
[No Abstract] [Full Text] [Related]
18. Molecular targeting for treatment of advanced hepatocellular carcinoma.
Song IH
Korean J Hepatol; 2009 Sep; 15(3):299-308. PubMed ID: 19783879
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
Han KH; Park JY
J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
[No Abstract] [Full Text] [Related]
20. Sorafenib-induced hepatic encephalopathy.
Marks AB; Gerard R; Fournier P; Coupe P; Gautier S
Ann Pharmacother; 2009 Dec; 43(12):2121. PubMed ID: 19861429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
